Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations

Peer Review reports

Original Submission
13 Jul 2018	Submitted	Original manuscript
23 Oct 2018	Reviewed	Reviewer Report - Martin Connock
29 Nov 2018	Reviewed	Reviewer Report - Rachid Rafia
10 Jan 2019	Author responded	Author comments - Jesse Elliott
Resubmission - Version 2
10 Jan 2019	Submitted	Manuscript version 2
Publishing
15 Mar 2019	Editorially accepted
27 Mar 2019	Article published	10.1186/s13643-019-0990-z

Back to article page